首页> 外文OA文献 >Correction to: A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015–2017

【2h】

Correction to: A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015–2017

机译：矫正：从替诺福韦富马酸薄荷（TDF）转换的艾滋病毒阳性患者重量变化的回顾性分析 - 到2015 - 2017年一家德国大学医院的替诺夫罗昔芬酰胺富马酸盐（TAF）治疗方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Mario Gomez; Ulrich Seybold; Julia Roider; Georg Härter; Johannes R. Bogner;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017 (vol 47, pg 95, 2019) [J] . Gomez Mario, Seybold Ulrich, Roider Julia, Infection . 2019,第1期

机译：从替诺福韦解毒富马酸核（TDF）转换的艾滋病毒阳性患者重量变化的回顾性分析 - 2015-2017在一家德国大学医院的Tenofovir Alafenide富马酸骨液（TAF）治疗方案（Vol 47，PG 95,2019 的）
2. A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017 [J] . Gomez Mario, Seybold Ulrich, Roider Julia, Infection . 2019,第1期

机译：从替诺福韦解毒富马酸盐（TDF）转换的艾滋病毒阳性患者重量变化的回顾性分析 - 对德国大学医院的替诺福韦醛芬酰胺富马酸（TAF）治疗方案在2015 - 2017年
3. Improved Bone and Renal Safety at 1 Year after Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Results from 2 Phase 3 Studies in HBeAg-positive and HBeAg-negative Patients with Chronic Hepatitis B (CHB) [J] . Pan Calvin Q., Brunetto Maurizia R., Hui Aric Josun, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：从替诺福韦毒性富马酸核（TDF）转向替诺福韦·阿拉芬酰胺（TAF）后1年改善骨骼和肾脏安全性：结果来自2阶段3研究的HBEAG阳性和HBEAG阴性慢性乙型肝炎（CHB）的研究结果
4. Week 48 Results of EMERALD: A Phase 3 Randomized Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (QD) Single-tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed HIV-1-infected Adults [O] . Chloe Orkin, Jean-Michel Molina, Joel Gallant, 2017

机译：EMERALD的第48周结果：第3阶段的非劣效性研究评估了从加强蛋白酶抑制剂（bPI）加恩曲他滨（FTC）/替诺福韦富马酸替诺福韦酯（TDF）转换为每日一次（QD）的功效和安全性）在病毒学上被抑制感染了HIV-1的成年人中Darunavir / Cobicistat / Emtricitabine / Tenofovir Alafenamide（D / C / F / TAF）的单片治疗方案（STR）
5. IDDF2020-ABS-0060 Impact of prior tenofovir disoproxil fumarate (TDF) treatment duration on tenofovir alafenamide (TAF) safety profile in virally suppressed chronic HBV patients switched from TDF to TAF [O] . Henry Lik Yuen Chan, Pietro Lampertico, Sang Hoon Ahn, 2020

机译：IDDF2020-ABS-ABS-0060对Tenofovir umarovir umarate（TDF）治疗持续时间在替诺福韦anafenamide（TAF）的慢性HBV患者在从TDF转换为TAF

Correction to: A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015–2017

著录项

相似文献

相关主题

期刊订阅